Hepatitis E Virus (eBook)
XI, 246 Seiten
Springer Netherlands (Verlag)
978-94-024-0942-0 (ISBN)
This book systematically and comprehensively discusses the biological, epidemiological and clinical characteristics of the hepatitis E virus (HEV). It presents current knowledge of HEV and explores experimental methods, treatment and prevention of HEV. First identified in the 1980s and cloned in 1990, HEV is the causative agent of Hepatitis E, which mainly occurs in developing regions, such as Southeast Asia, Middle East and Africa, and significantly affects the health of the people in these areas. It is estimated that a third of the world's population has been infected with HEV, which is transmitted via the fecal-oral route and can infect both human and animals.
The book provides an overview of HEV from benchside to bedside. It is a valuable resource for researchers in the field and those in the pharmaceutical industry developing HEV vaccines, as well as physicians involved in identifying and treating those infected with the virus.Dr. Youchun Wang is a professor and deputy director of National Institute for Food and Drug Control. He has also held several positions in academic associations, including as the Vice Chairman of the Medical Microbiology and Immunology in the Chinese Medical Association and Vice Chairman of Medical Virology in the Chinese Medical Association, Vice Chairman of the Chinese Laboratory Animal Association, Chairman of Beijing Medical Virology, and Vice Chairman of Virological Products of the Chinese Pharmacopoeia. He has mainly worked on the hepatitis viruses, human immunodeficiency virus, human papillomavirus, and other viruses. He has published more than 200 academic papers as the first or corresponding author, 60 of which were published in Science Citation Index journals.
This book systematically and comprehensively discusses the biological, epidemiological and clinical characteristics of the hepatitis E virus (HEV). It presents current knowledge of HEV and explores experimental methods, treatment and prevention of HEV. First identified in the 1980s and cloned in 1990, HEV is the causative agent of Hepatitis E, which mainly occurs in developing regions, such as Southeast Asia, Middle East and Africa, and significantly affects the health of the people in these areas. It is estimated that a third of the world's population has been infected with HEV, which is transmitted via the fecal-oral route and can infect both human and animals. The book provides an overview of HEV from benchside to bedside. It is a valuable resource for researchers in the field and those in the pharmaceutical industry developing HEV vaccines, as well as physicians involved in identifying and treating those infected with the virus.
Dr. Youchun Wang is a professor and deputy director of National Institute for Food and Drug Control. He has also held several positions in academic associations, including as the Vice Chairman of the Medical Microbiology and Immunology in the Chinese Medical Association and Vice Chairman of Medical Virology in the Chinese Medical Association, Vice Chairman of the Chinese Laboratory Animal Association, Chairman of Beijing Medical Virology, and Vice Chairman of Virological Products of the Chinese Pharmacopoeia. He has mainly worked on the hepatitis viruses, human immunodeficiency virus, human papillomavirus, and other viruses. He has published more than 200 academic papers as the first or corresponding author, 60 of which were published in Science Citation Index journals.
Hepatitis E virus (HEV) biology.- Characteristics and functions of HEV proteins.- Epidemiology of hepatitis E.- Hepatitis E as a zoonosis.- Genetic evolution of HEV.- Transmission of HEV.- Immunobiology and host response.- HEV cell culture systems.- HEV animal models.- Clinical manifestations of hepatitis E.- Laboratory diagnosis of HEV infection.- Treatment of HEV infection.- Prophylactic Hepatitis E vaccine
| Erscheint lt. Verlag | 13.10.2016 |
|---|---|
| Reihe/Serie | Advances in Experimental Medicine and Biology | Advances in Experimental Medicine and Biology |
| Zusatzinfo | XI, 246 p. 35 illus., 14 illus. in color. |
| Verlagsort | Dordrecht |
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie ► Allgemeines / Lexika |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Mikrobiologie / Infektologie / Reisemedizin | |
| Studium ► Querschnittsbereiche ► Epidemiologie / Med. Biometrie | |
| Studium ► Querschnittsbereiche ► Infektiologie / Immunologie | |
| Naturwissenschaften ► Biologie ► Mikrobiologie / Immunologie | |
| Technik | |
| Schlagworte | Diagnosis • disease prevention • Hepatitis E Virus • Infectious Diseases • Molecular Biology • vaccines • Virus Genetics • zoonosis |
| ISBN-10 | 94-024-0942-4 / 9402409424 |
| ISBN-13 | 978-94-024-0942-0 / 9789402409420 |
| Haben Sie eine Frage zum Produkt? |
PDF (Wasserzeichen)Größe: 5,2 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
